Celebrating the discovery of mutated CALR
What is
essential
thrombocythemia
(ET)?
Most commonly diagnosed in women over the age of 50, ET is associated with a proliferation of platelet precursors in the bone marrow and complications frequently include blood clotting and/or bleeding.
Learn more about ETWhat is
polycythemia vera
(PV)?
The disease is most common in men over the age of 60, but anyone can develop PV. PV patients typically experience an elevated red blood cell count, an elevated platelet count and an enlarged spleen, especially over time.
Learn more about PVWhat is
myelofibrosis
(MF)?
MF is a chronic blood cancer in which excessive scar tissue forms in the bone marrow and impairs its ability to produce normal blood cells.
Learn more about MFEvery patient experience is unique and provides new clues for researchers and clinicians.
In our 24-year history, MPNRF has contributed to some of the most influential MPN research discoveries.
Engage with us to ensure that new therapies have the maximum impact on patient outcomes and quality of life.
Download our Voice of the Patient report
Julie and her family joined team MPN and created HikeMF to join the fight against MPNs.
Your investment supports doctors and researchers around the world who are dedicated to finding cures for MPNs.
MPN Pathways: Empowered Voices in Research Bonus Session Summary — What’s Your Why?
MPN NEWS | April 25, 2025
MPN Pathways: Empowered Voices in Research bonus session — What’s your why? At MPN Research Foundation, we are dedicated to ensuring that the patient’s voice is at the forefront of our work. As we grow in our role as a patient-centered research foundation, we continue to take intentional steps to bridge the intersection of patients,… Read More »MPN Pathways: Empowered Voices in Research Bonus Session Summary — What’s Your Why?
Hematologist discovers the kidneys: One researcher’s quest to explain an overlooked MPN complication
MPN NEWS | April 25, 2025
Profile: Brandi Reeves, MDUniversity of North Caroline at Chapel Hill Hematologist discovers the kidneys: One researcher’s quest to explain an overlooked MPN complication It all started with a series of patients who couldn’t qualify for a clinical trial. Not for lack of interest — one after another, patients with myeloproliferative neoplasms (MPNs) couldn’t meet enrollment criteria.… Read More »Hematologist discovers the kidneys: One researcher’s quest to explain an overlooked MPN complication
Dr. Simón Méndez-Ferrer Research Profile
MPN NEWS | March 20, 2025
Profile: Simón Méndez-Ferrer, PhDRutgers University Beyond mutant cells: Dr. Simón Méndez-Ferrer on the role of the bone marrow environment in myelofibrosis (MF). In a healthy body, the bone marrow is a bustling ecosystem, teeming with diverse cellular species, each playing a supportive role and maintaining balance. Stem cells stand at the heart of this environment,… Read More »Dr. Simón Méndez-Ferrer Research Profile
Join our community to get the latest research, patient stories, and exclusive content delivered right to your inbox. Plus, when you subscribe, receive the latest NCCN guidelines and resources to support your journey.
JOIN OVER 20,000 SUBSCRIBERS. UNSUBSCRIBE ANYTIME.